Viscosupplementation Market by Product (Single injection, Three injection, Five injection), by Region (North America, Europe, Asia Pacific, Latin America, MEA) and Segment Forecasts, 2014 - 2025

  • ID: 4396500
  • Report
  • Region: Asia, Asia Pacific, Europe, North America, United States
  • 87 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Ferring B.V.
  • LG Life Sciences Ltd
  • Lifecore Biomedical, LLC
  • Sanofi
  • Seikagaku Corporation
  • MORE
The global viscosupplementation market is expected to reach USD 6.52 billion by 2025, based on this new report. The market is expected to observer an exponential growth over the next 9 years due to the increasing incidence of osteoarthritis, wounds, gingivitis, & ulcers and growing base of the geriatric population are some high-impact rendering drivers of the viscosupplements market.

Estimates published by the WHO suggest that the global population of the age group 65 years and above is anticipated to rise from 7% in 2000 to 16% in 2050. An associated consequence of this increase in the geriatric population will be an increase in the incidence of obesity and osteoarthritis. Along with growing preference for minimally invasive surgeries, global increase in the target population is expected to significantly propel demand for viscosupplementations throughout the forecast period.

Further Key Findings From The Study Suggest:
  • Three injection dominated the market in 2016, closely followed by single injection. It can be owing to the prolonged presence and holding a significant share of this market.
  • Single injection is anticipated to be one of the fastest growing segment owing to the increase in convenience, reduced hospital visits, and reduced adverse effects & associated pain
  • Geographically, Asia Pacific held the largest market share in 2016 and is expected to maintain its position during the forecast period. This large share can be accounted for by the presence of a sizeable base of geriatric population, which is more susceptible to disorders such as osteoarthritis and rheumatoid arthritis. Moreover, growing demand for minimally invasive procedures is a significant factor contributing to the large share of Asia Pacific.
  • Due to the presence of high unmet medical needs in emerging economies, such Brazil, growing awareness about applications of minimally invasive techniques, and increasing disposable income, the Latin American market is expected to grow at a lucrative rate in the coming years
  • Some key industry contributors are Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Holdings Inc, Bioventus, Ferring B.V., Lifecore Biomedical, LLC, and LG Life Sciences Ltd


PLEASE NOTE:
This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Ferring B.V.
  • LG Life Sciences Ltd
  • Lifecore Biomedical, LLC
  • Sanofi
  • Seikagaku Corporation
  • MORE
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis

Chapter 2 Executive Summary

Chapter 3 Market Snapshot

Chapter 4 Viscosupplementation Market Variables, Trends& Scope
4.1 Market Segmentation and Scope
4.1.1 Market Driver Analysis
4.1.1.1 Increasing geriatric population
4.1.1.2 High prevalence of orthopedic disorders
4.1.2 Market Restraint Analysis
4.1.2.1 High cost and side effects associated with hyaluronic acid cycles
4.2 Penetration & Growth Prospects Mapping
4.3 Viscosupplementation Market - PESTLE Analysis
4.4 Industry Analysis - Porter’s
4.5 Viscosupplementation Competitive Landscape: Market position analysis (based on products, regional presence

Chapter 5 Viscosupplementation Market: Product Estimates & Trend Analysis
5.1 Viscosupplementation Market: Product Movement Analysis
5.2 Single Injection
5.2.1 Single-injection market, 2014 - 2025 (USD Million)
5.3 Three Injection
5.3.1 Three-injection market, 2014 - 2025 (USD Million)
5.4 Five Injection
5.4.1 Five-injection market, 2014 - 2025 (USD Million)

Chapter 6 Viscosupplementation Market: Regional Estimates & Trend Analysis, by Product
6.1 Viscosupplementation Market Share, by Region, 2016 & 2025
6.2 North America
6.2.1 U.S.
6.2.1.1 U.S. viscosupplementation market, 2014 - 2025 (USD Million)
6.2.2 Canada
6.2.2.1 Canada viscosupplementation market, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 UK
6.3.1.1 UK viscosupplementation market, 2014 - 2025 (USD Million)
6.3.2 France
6.3.2.1 France viscosupplementation market, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific viscosupplementation market, 2014 - 2025 (USD Million)
6.4.2 Japan
6.4.2.1 Japan viscosupplementation market, 2014 - 2025 (USD Million)
6.4.3 China
6.4.3.1 China viscosupplementation market, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America viscosupplementation market, 2014 - 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil viscosupplementation market, 2014 - 2025 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico viscosupplementation market, 2014 - 2025 (USD Million)
6.6 MEA
6.6.1 MEA viscosupplementation market, 2014 - 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa viscosupplementation market, 2014 - 2025 (USD Million)

Chapter 7 Reimbursement Outlook
7.1 Reimbursement by Product
7.1.1 Gel-one
7.1.2 EUFLEXXA
7.1.3 Synvisc-One
7.1.4 Supartz
7.1.5 Hyalgan
7.1.6 Monovisc
7.1.7 Orthovisc

Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Company Profiles
8.2.1 Sanofi
8.2.1.1 Company overview
8.2.1.2 Financial performance
8.2.1.3 Product benchmarking
8.2.1.4 Strategic initiatives
8.2.2 Anika Therapeutics, Inc.
8.2.2.1 Company overview
8.2.2.2 Financial performance
8.2.2.3 Product benchmarking
8.2.2.4 Strategic initiatives
8.2.3 Seikagaku Corporation
8.2.3.1 Company overview
8.2.3.2 Financial performance
8.2.3.3 Product benchmarking
8.2.3.4 Strategic initiatives
8.2.4 Zimmer Biomet
8.2.4.1 Company overview
8.2.4.2 Financial performance
8.2.4.3 Product benchmarking
8.2.4.4 Strategic initiatives
8.2.5 Smith & Nephew Plc
8.2.5.1 Company overview
8.2.5.2 Financial performance
8.2.5.3 Product benchmarking
8.2.5.4 Strategic initiatives
8.2.6 Ferring B.V.
8.2.6.1 Company overview
8.2.6.2 Product benchmarking
8.2.6.3 Strategic initiatives
8.2.7 Lifecore Biomedical, LLC
8.2.7.1 Company overview
8.2.7.2 Financial performance
8.2.7.3 Product benchmarking
8.2.7.4 Strategic initiatives
8.2.8 LG Life Sciences Ltd
8.2.8.1 Company overview
8.2.8.2 Product benchmarking
8.2.8.3 Strategic initiatives

List of Tables
Table 1 North America Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
Table 2 North America Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 3 U.S. Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 4 Canada Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 5 Europe Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
Table 6 Europe Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 7 UK Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 8 France Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 9 Asia Pacific Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
Table 10 Asia Pacific Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 11 Japan Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 12 China Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 13 Latin America Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
Table 14 Latin America Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 15 Brazil Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 16 Mexico Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 17 MEA Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
Table 18 MEA Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 19 South Africa Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
Table 20 Cost of viscosupplementations- A driving factor (US)
Table 21 NYS non-coverage details
Table 22 HCPCS Code
Table 23 Labeling Instructions by the FDA
Table 24 Distribution and marketing rights of Synvisc

List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing &forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market summary
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Ratio of adult population to total population (billion)
Figure 12 Market restraint relevance analysis (Current &future impact)
Figure 13 Penetration & growth prospect mapping
Figure 14 Viscosupplementation Market - PESTLE Analysis
Figure 15 Porter’s Five Forces Analysis
Figure 16 Viscosupplementation market: Heat map analysis
Figure 17 Viscosupplementation market product outlook key takeaways
Figure 18 Viscosupplementation market: Product movement analysis
Figure 19 Global single-injection market, 2014 - 2025 (USD Million)
Figure 20 Global three-injection market, 2014 - 2025 (USD Million)
Figure 21 Global five-injection market, 2014 - 2025 (USD Million)
Figure 22 Regional market place: Key takeaways
Figure 23 Regional outlook, 2016 & 2025
Figure 24 North America viscosupplementation market, 2014 - 2025 (USD Million)
Figure 25 U.S. viscosupplementation market, 2014 - 2025 (USD Million)
Figure 26 Canada viscosupplementation market, 2014 - 2025 (USD Million)
Figure 27 Europe viscosupplementation market, 2014 - 2025 (USD Million)
Figure 28 UK viscosupplementation market, 2014 - 2025 (USD Million)
Figure 29 France viscosupplementation market, 2014 - 2025 (USD Million)
Figure 30 Asia Pacific viscosupplementation market, 2014 - 2025 (USD Million)
Figure 31 Japan viscosupplementation market, 2014 - 2025 (USD Million)
Figure 32 China viscosupplementation market, 2014 - 2025 (USD Million)
Figure 33 Latin America viscosupplementation market, 2014 - 2025 (USD Million)
Figure 34 Brazil viscosupplementation market, 2014 - 2025 (USD Million)
Figure 35 Mexico viscosupplementation market, 2014 - 2025 (USD Million)
Figure 36 MEA viscosupplementation market, 2014 - 2025 (USD Million)
Figure 37 South Africa viscosupplementation market, 2014 - 2025 (USD Million)
Figure 38 Strategy framework
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Sanofi
  • Anika Therapeutics, Inc.
  • Seikagaku Corporation
  • Zimmer Biomet
  • Smith & Nephew Plc
  • Ferring B.V.
  • Lifecore Biomedical, LLC
  • LG Life Sciences Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll